Hinge Health Inc HNGE.N, HNGE.K is expected to report resultson August 5 for the period ending June 30 2025
The San Francisco California-based company is expected to report revenue of $125.35 million, according to the mean estimate from 11 analysts, based on LSEG data.
LSEG's mean analyst estimate for Hinge Health Inc is for earnings of 9 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 13 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The average consensus recommendation for the healthcare facilities & services peer group is also "Buy".
Wall Street's median 12-month price target for Hinge Health Inc is $49.00, about 8.3% above its last closing price of $44.95
This summary was machine generated August 1 at 22:21 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)